
Genitourinary Drugs Global Market Report 2025
Description
Genitourinary Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on genitourinary drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for genitourinary drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The genitourinary drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Product: Urologicals; Hormonal Therapy; Gynecological; Anti-Infectives; Other Products
2) By Route Of Administration: Oral; Parenteral; Topical
3) By Application: Urinary Tract Infections (UTIs); Benign Prostatic Hyperplasia (BPH); Prostate Cancer; Overactive Bladder; Bladder Cancer; Other Applications
4) By Distribution Channel: Hospital Pharmacies; Drug Store And Retail Pharmacies; Online Pharmacies
Subsegments:
1) By Urologicals: Benign Prostatic Hyperplasia (BPH) Drugs; Urinary Incontinence Drugs; Overactive Bladder (OAB) Drugs; Urolithiasis (Kidney Stone) Drugs; Erectile Dysfunction Drugs
2) By Hormonal Therapy: Estrogen Therapy; Progestin Therapy; Gonadotropin-Releasing Hormone (GnRH) Agonists/Antagonists; Androgen Replacement Therapy; Selective Estrogen Receptor Modulators (SERMs)
3) By Gynecological: Contraceptives; Menopausal Hormone Therapy; Fertility Drugs; Drugs for Endometriosis; Drugs for Polycystic Ovary Syndrome (PCOS)
4) By Anti-Infectives: Urinary Tract Infection (UTI) Drugs; Sexually Transmitted Infection (STI) Drugs; Vaginal Antifungals; Antivirals
5) By Other Products: Drugs for Chronic Pelvic Pain; Bladder Cancer Therapies; Interstitial Cystitis Drugs; Pelvic Organ Prolapse Treatment Drugs; Adjunctive Therapies
Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche AG; Merck & Co. Inc.; Bayer AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on genitourinary drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for genitourinary drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The genitourinary drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Product: Urologicals; Hormonal Therapy; Gynecological; Anti-Infectives; Other Products
2) By Route Of Administration: Oral; Parenteral; Topical
3) By Application: Urinary Tract Infections (UTIs); Benign Prostatic Hyperplasia (BPH); Prostate Cancer; Overactive Bladder; Bladder Cancer; Other Applications
4) By Distribution Channel: Hospital Pharmacies; Drug Store And Retail Pharmacies; Online Pharmacies
Subsegments:
1) By Urologicals: Benign Prostatic Hyperplasia (BPH) Drugs; Urinary Incontinence Drugs; Overactive Bladder (OAB) Drugs; Urolithiasis (Kidney Stone) Drugs; Erectile Dysfunction Drugs
2) By Hormonal Therapy: Estrogen Therapy; Progestin Therapy; Gonadotropin-Releasing Hormone (GnRH) Agonists/Antagonists; Androgen Replacement Therapy; Selective Estrogen Receptor Modulators (SERMs)
3) By Gynecological: Contraceptives; Menopausal Hormone Therapy; Fertility Drugs; Drugs for Endometriosis; Drugs for Polycystic Ovary Syndrome (PCOS)
4) By Anti-Infectives: Urinary Tract Infection (UTI) Drugs; Sexually Transmitted Infection (STI) Drugs; Vaginal Antifungals; Antivirals
5) By Other Products: Drugs for Chronic Pelvic Pain; Bladder Cancer Therapies; Interstitial Cystitis Drugs; Pelvic Organ Prolapse Treatment Drugs; Adjunctive Therapies
Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche AG; Merck & Co. Inc.; Bayer AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
175 Pages
- 1. Executive Summary
- 2. Genitourinary Drugs Market Characteristics
- 3. Genitourinary Drugs Market Trends And Strategies
- 4. Genitourinary Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 5. Global Genitourinary Drugs Growth Analysis And Strategic Analysis Framework
- 5.1. Global Genitourinary Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Genitourinary Drugs Market Growth Rate Analysis
- 5.4. Global Genitourinary Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Genitourinary Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Genitourinary Drugs Total Addressable Market (TAM)
- 6. Genitourinary Drugs Market Segmentation
- 6.1. Global Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Urologicals
- Hormonal Therapy
- Gynecological
- Anti-Infectives
- Other Products
- 6.2. Global Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral
- Parenteral
- Topical
- 6.3. Global Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Urinary Tract Infections (Utis)
- Benign Prostatic Hyperplasia (BPH)
- Prostate Cancer
- Overactive Bladder
- Bladder Cancer
- Other Applications
- 6.4. Global Genitourinary Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacies
- Drug Store And Retail Pharmacies
- Online Pharmacies
- 6.5. Global Genitourinary Drugs Market, Sub-Segmentation Of Urologicals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Benign Prostatic Hyperplasia (BPH) Drugs
- Urinary Incontinence Drugs
- Overactive Bladder (OAB) Drugs
- Urolithiasis Drugs
- Erectile Dysfunction Drugs
- 6.6. Global Genitourinary Drugs Market, Sub-Segmentation Of Hormonal Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Estrogen Therapy
- Progestin Therapy
- Gonadotropin-Releasing Hormone (GnRH) Agonists/Antagonists
- Androgen Replacement Therapy
- Selective Estrogen Receptor Modulators (SERMs)
- 6.7. Global Genitourinary Drugs Market, Sub-Segmentation Of Gynecological, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Contraceptives
- Menopausal Hormone Therapy
- Fertility Drugs
- Drugs For Endometriosis
- Drugs For Polycystic Ovary Syndrome (PCOS)
- 6.8. Global Genitourinary Drugs Market, Sub-Segmentation Of Anti-Infectives, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Urinary Tract Infection (UTI) Drugs
- Sexually Transmitted Infection (STI) Drugs
- Vaginal Antifungals
- Antivirals
- 6.9. Global Genitourinary Drugs Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Drugs For Chronic Pelvic Pain
- Bladder Cancer Therapies
- Interstitial Cystitis Drugs
- Pelvic Organ Prolapse Treatment Drugs
- Adjunctive Therapies
- 7. Genitourinary Drugs Market Regional And Country Analysis
- 7.1. Global Genitourinary Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Genitourinary Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Genitourinary Drugs Market
- 8.1. Asia-Pacific Genitourinary Drugs Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Genitourinary Drugs Market
- 9.1. China Genitourinary Drugs Market Overview
- 9.2. China Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Genitourinary Drugs Market
- 10.1. India Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Genitourinary Drugs Market
- 11.1. Japan Genitourinary Drugs Market Overview
- 11.2. Japan Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Genitourinary Drugs Market
- 12.1. Australia Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Genitourinary Drugs Market
- 13.1. Indonesia Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Genitourinary Drugs Market
- 14.1. South Korea Genitourinary Drugs Market Overview
- 14.2. South Korea Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Genitourinary Drugs Market
- 15.1. Western Europe Genitourinary Drugs Market Overview
- 15.2. Western Europe Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Genitourinary Drugs Market
- 16.1. UK Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Genitourinary Drugs Market
- 17.1. Germany Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Genitourinary Drugs Market
- 18.1. France Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Genitourinary Drugs Market
- 19.1. Italy Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Genitourinary Drugs Market
- 20.1. Spain Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Genitourinary Drugs Market
- 21.1. Eastern Europe Genitourinary Drugs Market Overview
- 21.2. Eastern Europe Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Genitourinary Drugs Market
- 22.1. Russia Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Genitourinary Drugs Market
- 23.1. North America Genitourinary Drugs Market Overview
- 23.2. North America Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Genitourinary Drugs Market
- 24.1. USA Genitourinary Drugs Market Overview
- 24.2. USA Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Genitourinary Drugs Market
- 25.1. Canada Genitourinary Drugs Market Overview
- 25.2. Canada Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Genitourinary Drugs Market
- 26.1. South America Genitourinary Drugs Market Overview
- 26.2. South America Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Genitourinary Drugs Market
- 27.1. Brazil Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Genitourinary Drugs Market
- 28.1. Middle East Genitourinary Drugs Market Overview
- 28.2. Middle East Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Genitourinary Drugs Market
- 29.1. Africa Genitourinary Drugs Market Overview
- 29.2. Africa Genitourinary Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Genitourinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Genitourinary Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Genitourinary Drugs Market Competitive Landscape And Company Profiles
- 30.1. Genitourinary Drugs Market Competitive Landscape
- 30.2. Genitourinary Drugs Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 31. Genitourinary Drugs Market Other Major And Innovative Companies
- 31.1. Novartis AG
- 31.2. Sanofi S.A.
- 31.3. Bristol Myers Squibb
- 31.4. AstraZeneca plc
- 31.5. Abbott Laboratories
- 31.6. GSK plc
- 31.7. Eli Lilly and Company
- 31.8. Amgen Inc.
- 31.9. Teva Pharmaceutical Industries Ltd.
- 31.10. Astellas Pharma Inc.
- 31.11. Ipsen Société Anonyme
- 31.12. Aurobindo Pharma Limited
- 31.13. Dr. Reddy's Laboratories Limited
- 31.14. Cipla Limited
- 31.15. Hikma Pharmaceuticals Public Limited Company
- 32. Global Genitourinary Drugs Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Genitourinary Drugs Market
- 34. Recent Developments In The Genitourinary Drugs Market
- 35. Genitourinary Drugs Market High Potential Countries, Segments and Strategies
- 35.1 Genitourinary Drugs Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Genitourinary Drugs Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Genitourinary Drugs Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.